. Metabolomics-driven identification of adenosine deaminase as therapeutic target in a mouse model of Parkinson's disease. J Neurochem. 2019 Aug;150(3):282-295. Epub 2019 Jun 25 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.